The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information: (link sends e-mail)

Study Name on (link is external)
Extension. Long-term Safety Study in CF Patients: Single Arm TIP
Study DrugTobramycin inhalation powder
Type of Study DrugAnti-infective
Study TitleA 48 Week Extension to CTBM100C2401, a Single Arm, Open-label, Multicenter, Phase IV Extension Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis Who Completed Participation in CTBM100C2401
Study Phase4
Study SponsorNovartis

Link on (link is external) (link is external)

Participating ECFS-CTN sitesItaly: Florence, Rome, Verona
Spain: Barcelona
Age6 Years and older